Correlation Between Catalent and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Catalent and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalent and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalent and CanSino Biologics, you can compare the effects of market volatilities on Catalent and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalent with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalent and CanSino Biologics.

Diversification Opportunities for Catalent and CanSino Biologics

-0.5

Correlation Coefficient

Catalent  CanSino Biologics

Very good diversification

The 3 months correlation between Catalent and CanSino is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Catalent and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Catalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalent are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Catalent i.e., Catalent and CanSino Biologics go up and down completely randomly.

Pair Corralation between Catalent and CanSino Biologics

Given the investment horizon of 90 days Catalent is expected to under-perform the CanSino Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Catalent is 7.76 times less risky than CanSino Biologics. The stock trades about -0.07 of its potential returns per unit of risk. The CanSino Biologics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  206.00  in CanSino Biologics on January 25, 2024 and sell it today you would earn a total of  4.00  from holding CanSino Biologics or generate 1.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Catalent  vs.  CanSino Biologics

Catalent

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady essential indicators, Catalent may actually be approaching a critical reversion point that can send shares even higher in May 2024.

CanSino Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CanSino Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, CanSino Biologics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Catalent and CanSino Biologics

The main advantage of trading using opposite Catalent and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalent position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Catalent and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.